Understanding how the DEA classifies cannabis compounds is essential for patients and providers navigating the increasingly complex legal landscape between hemp, CBD, and controlled substances. The DEA has published an updated collection of cannabis-related regulatory and scheduling documents, providing a consolidated federal reference for the current legal classification and enforcement framework surrounding marijuana and hemp-derived cannabinoids. These documents detail the Controlled Substances Act scheduling criteria, enforcement guidance, and regulatory interpretations that shape how cannabis products are classified at the federal level.